Skip to main content

Bullish on Biotech? The BBH ETF is Not Just a 2020 Play

The COVID-19 pandemic has given way to new technological innovations in the biotechnology sector with respect to creating a vaccine. ETF investors looking for a play that can take them well into 2021 might find the VanEck Vectors® Biotech ETF (BBH) appealing. The fund seeks to replicate as closely...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.